⌘K
Cornucopian Capital
Deals on record
1
Common Fundraising Type
Seed
Archon Biosciences
AI-driven • Computational protein design
Archon Biosciences develops AI-driven Antibody Cages to enhance antibody treatments by improving target engagement and biodistribution.